Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: Comparative studies against doxorubicin and mitoxantrone Ennio CavallettiLuca CrippaFranca Sala PRECLINICAL STUDIES 07 February 2007 Pages: 187 - 195
Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers Amit KokateXiaoling LiBhaskara Jasti Preclinical Studies 05 December 2006 Pages: 197 - 203
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments Axel-Rainer HanauskeOlaf OberschmidtUlrike Eismann PRECLINICAL STUDIES 09 March 2007 Pages: 205 - 210
Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors S. KalmadiM. DavisT. Mekhail Phase I Studies 11 November 2006 Pages: 211 - 216
A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours Tara BaetzElizabeth EisenhauerMalcolm Moore Phase I Studies 05 December 2006 Pages: 217 - 225
Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors I. E. L. M. KuppensP. O. WitteveenJ. H. M. Schellens Phase I Studies 05 December 2006 Pages: 227 - 235
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers Sanjay GoelKavita DesaiSridhar Mani Phase I Studies 30 December 2006 Pages: 237 - 245
A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma Richard KeffordJane McNeil BeithMartine Clozel PHASE II STUDIES 05 October 2006 Pages: 247 - 252
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Takashi YanaShunichi NegoroMasahiro Fukuoka OriginalPaper 13 October 2006 Pages: 253 - 258
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme Tom MikkelsenRichard LushSteve Rosenfeld Phase II Studies 01 November 2006 Pages: 259 - 263
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma Matthew D. GalskySvetlana MironovDean F. Bajorin Phase II Studies 05 December 2006 Pages: 265 - 270
Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) Liangli ZhaoElaine S. MarshallBruce C. Baguley Short Report 03 January 2007 Pages: 271 - 276
Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy C. A. SteinSanjay GoelReza Ghavamian Short Report 11 January 2007 Pages: 277 - 278
Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel Stephan A. VeltkampJetske M. Meerum TerwogtSjoerd Rodenhuis Case Report 13 January 2007 Pages: 279 - 281
Investigational New Drugs, Volume 25, Number 1 Springer Publishing Department Erratum 22 March 2007 Pages: 283 - 283